Section
F13.2
Sedative, hypnotic or anxiolytic-related dependence
Hierarchy
-
F01-F99 Mental, Behavioral and Neurodevelopmental disorders (F01-F99)
-
F10-F19 Mental and behavioral disorders due to psychoactive substance use (F10-F19)
-
F13 Sedative, hypnotic, or anxiolytic related disorders
-
F13.2 Sedative, hypnotic or anxiolytic-related dependence
-
F13.20 Sedative, hypnotic or anxiolytic dependence, uncomplicated
-
F13.21 Sedative, hypnotic or anxiolytic dependence, in remission
-
F13.22 Sedative, hypnotic or anxiolytic dependence with intoxication
-
F13.23 Sedative, hypnotic or anxiolytic dependence with withdrawal
-
F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
-
F13.25 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder
-
F13.26 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
-
F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
-
F13.28 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorders
-
F13.29 Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder
-
-
-
-
Includes
-
disorders of psychological development
Excludes 1
Excludes 2
F13.2
-
sedative, hypnotic, or anxiolytic poisoning (T42.-)
- T42 Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs
-
symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)
- R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)